ABVC BioPharma

ABVC BioPharma (formerly known as American BriVision) is a biotechnology company that identifies and commercializes new drugs and medical devices. It searches for candidates and inventions, discusses pre-clinical results, negotiates the rights to develop, conducts Phase I and Phase II studies, and partners with pharmaceutical companies for Phase III clinical studies and market launch. The company focuses on such diseases as myelodysplastic syndrome (MDS), depressive disorders, attention-deficit hyperactivity disorder (ADHD), oncology, and ophthalmology disorders.